Home > Insider Trading > Filing (0001179110-12-001708)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1526119	Verastem Inc.	VSTM	Pharmaceutical Preparations (2834)	273269467

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219015	K John Clarke	C/O Verastem, Inc. 215 First Street, Suite 440 Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-02-01	1,142,857	$0.00	1,142,857	No	4	C	Indirect	By CHP III, L.P.
Common Stock	Acquisiton	2012-02-01	714,285	$0.00	1,857,142	No	4	C	Indirect	By CHP III, L.P.
Common Stock	Acquisiton	2012-02-01	126,984	$0.00	1,984,126	No	4	C	Indirect	By CHP III, L.P.
Common Stock	Acquisiton	2012-02-01	250,000	$10.00	2,234,126	No	4	P	Indirect	By CHP III, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By CHP III, L.P.
No	4	C	Indirect	By CHP III, L.P.
No	4	C	Indirect	By CHP III, L.P.
No	4	P	Indirect	By CHP III, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2012-02-01	4,000,000	$0.00	1,142,857	$0.00
Common Stock	Series B Preferred Stock	Disposition	2012-02-01	2,500,000	$0.00	714,285	$0.00
Common Stock	Series C Preferred Stock	Disposition	2012-02-01	444,444	$0.00	126,984	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of preferred stock automatically converted into approximately 0.29 shares of common stock upon the closing of the issuer's initial public offering without payment of consideration.
Not applicable.
The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed anadmission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.